Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? – In the search for minimizing of the adverse effects of PAMAM administration.
All authors: Labieniec-Watala M, Przygodzki T, Sebekova K, Watala C
International Journal of Pharmaceutics, 464 (1-2): 152-167, 2014
http://ac.els-cdn.com/S0378517314000210/1-s2.0-S0378517314000210-main.pdf?_tid=6d2c905a-fd1b-11e3-8982-00000aacb35d&acdnat=1403778179_ff9faa3db547055a449a814804804631